Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Tumor
100%
Fibroblast Growth Factor Receptor 1 (FGFR1)
100%
Malignancy
100%
Molecular Targets
100%
Phosphotyrosine
100%
Prevention of Progression
100%
Malignant Phenotype
25%
Rational Design
12%
Transcriptionally Active
12%
Epithelial Cells
12%
Cell Proliferation
12%
Proliferative Response
12%
Cell Population
12%
Mitogen-activated Protein Kinase
12%
Receptor-interacting Protein Kinase 1 (RIPK1)
12%
Aging
12%
Age-dependent
12%
Epithelium
12%
Life-threatening
12%
Dietary Intervention
12%
Rat Prostate
12%
Slow Progression
12%
Tyrosine
12%
Transplantable
12%
Phospholipase
12%
Mitogenic Response
12%
Pharmaceutical Intervention
12%
Nonmalignant
12%
Cell Support
12%
Parenchymatous Organs
12%
Tumor Epithelial Cells
12%
Organ Homeostasis
12%
Non-malignant Tumor
12%
Medicine and Dentistry
Cancer
100%
Prostate Tumor
100%
Fibroblast Growth Factor Receptor 1
100%
Phosphotyrosine
100%
Epithelial Cell
28%
Malignant Neoplasm
14%
Cell Proliferation
14%
Homeostasis
14%
Phosphotransferase
14%
Kinase Signaling
14%
Cell Population
14%
Cell Signaling Pathway
14%
extracellular signal regulated kinase
14%
Stroma
14%
Fibroblast Growth Factor Receptor
14%
Mitogenesis
14%
Phospholipase
14%
Tumor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Tumor
100%
Molecular Target
100%
Phosphotyrosine
100%
Fibroblast Growth Factor Receptor 1
100%
Malignant Neoplasm
14%
Phosphotransferase
14%
Mitogen Activated Protein Kinase
14%
Phospholipase
14%
Fibroblast Growth Factor Receptor
14%
Neuroscience
Phosphotyrosine
100%
Fibroblast Growth Factor Receptor 1
100%
Epithelial Cells
28%
Cell Proliferation
14%
Kinase
14%
extracellular signal regulated kinase
14%
Cell Signaling
14%
Mitogenesis
14%
Phospholipase
14%
Fibroblast Growth Factor Receptor
14%
Immunology and Microbiology
Fibroblast Growth Factor Receptor 1
100%
Homeostasis
14%
Mitogen
14%
Cell Population
14%
Cell Proliferation
14%
Tyrosine
14%
Stroma
14%
Isotype
14%
Fibroblast Growth Factor
14%
Mitogenesis
14%